See more : Utron Ltd (UTRN.TA) Income Statement Analysis – Financial Results
Complete financial analysis of TTK Healthcare Limited (TTKHLTCARE.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TTK Healthcare Limited, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Investeringsforeningen Wealth Invest – Timeinvest Sustainable Opportunities AKL (WEITISOP.CO) Income Statement Analysis – Financial Results
- Eagle Point Credit Company Inc. (ECC) Income Statement Analysis – Financial Results
- Twin Vee Powercats Co. (VEEE) Income Statement Analysis – Financial Results
- Tianjin Development Holdings Limited (0882.HK) Income Statement Analysis – Financial Results
- Edwards Lifesciences Corporation (EW) Income Statement Analysis – Financial Results
TTK Healthcare Limited (TTKHLTCARE.NS)
About TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.53B | 7.25B | 5.96B | 6.33B | 6.45B | 6.26B | 5.76B | 5.30B | 5.15B | 4.83B | 4.16B | 3.82B | 3.54B | 3.10B | 2.52B | 2.20B | 1.99B | 2.11B | 1.87B | 1.53B |
| Cost of Revenue | 4.84B | 3.48B | 2.87B | 2.54B | 2.62B | 2.64B | 2.43B | 2.44B | 2.30B | 2.20B | 1.95B | 1.90B | 1.90B | 1.63B | 1.34B | 1.19B | 1.13B | 1.31B | 1.15B | 978.57M |
| Gross Profit | 2.69B | 3.77B | 3.09B | 3.79B | 3.83B | 3.62B | 3.33B | 2.86B | 2.85B | 2.63B | 2.21B | 1.92B | 1.64B | 1.48B | 1.18B | 1.00B | 859.90M | 803.03M | 716.79M | 551.42M |
| Gross Profit Ratio | 35.69% | 52.04% | 51.85% | 59.90% | 59.41% | 57.80% | 57.89% | 54.00% | 55.34% | 54.44% | 53.13% | 50.29% | 46.36% | 47.61% | 46.72% | 45.70% | 43.20% | 38.03% | 38.42% | 36.04% |
| Research & Development | 11.30M | 13.25M | 29.34M | 26.54M | 40.75M | 24.90M | 22.30M | 23.48M | 12.70M | 4.82M | 5.81M | 5.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 131.14M | 104.60M | 101.11M | 91.12M | 97.73M | 101.24M | 109.15M | 69.56M | 77.66M | 63.64M | 73.55M | 30.08M | 451.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.42B | 1.31B | 1.15B | 1.05B | 1.15B | 948.44M | 966.10M | 881.17M | 963.49M | 979.37M | 821.87M | 691.19M | 449.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.55B | 1.41B | 1.25B | 1.14B | 1.24B | 1.05B | 1.08B | 950.73M | 1.04B | 1.04B | 895.41M | 721.27M | 901.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 483.32M | 12.60M | 277.00K | 2.87M | 397.00K | 1.15M | 1.83B | 496.03K | 292.00K | 662.90K | 163.68K | -4.94M | 1.26B | 1.02B | 870.06M | -10.46M | -4.37M | -3.45M | -2.53M |
| Operating Expenses | 3.72B | 3.59B | 3.00B | 3.58B | 3.68B | 3.26B | 3.05B | 2.58B | 2.51B | 2.39B | 2.03B | 1.74B | 1.42B | 1.26B | 1.02B | 870.06M | 629.53M | 740.22M | 663.51M | 572.65M |
| Cost & Expenses | 7.28B | 7.07B | 5.87B | 6.12B | 6.30B | 5.90B | 5.48B | 5.02B | 4.81B | 4.58B | 3.98B | 3.64B | 3.32B | 2.88B | 2.37B | 2.06B | 1.76B | 2.05B | 1.81B | 1.55B |
| Interest Income | 621.09M | 463.06M | 146.61M | 98.67M | 82.50M | 74.28M | 74.19M | 45.36M | 54.72M | 64.96M | 58.80M | 56.49M | 46.30M | 33.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 27.56M | 52.39M | 32.38M | 21.04M | 31.49M | 32.59M | 46.39M | 29.95M | 32.37M | 35.15M | 28.62M | 24.34M | 25.60M | 18.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 130.59M | 128.06M | 125.84M | 130.20M | 143.77M | 146.69M | 152.42M | 119.16M | 72.07M | 61.40M | 31.74M | 27.20M | 23.58M | 19.71M | 18.18M | 17.47M | 19.60M | 28.81M | 27.31M | 25.88M |
| EBITDA | 999.35M | 796.81M | 406.58M | 373.52M | 370.70M | 573.07M | 501.19M | 442.08M | 460.62M | 361.17M | 258.28M | 268.85M | 284.66M | 258.38M | 173.20M | 151.22M | 249.98M | 91.63M | 80.59M | 4.64M |
| EBITDA Ratio | 13.28% | 11.00% | 6.54% | 7.13% | 5.90% | 9.33% | 8.81% | 8.36% | 8.98% | 7.62% | 6.41% | 6.87% | 8.07% | 7.77% | 6.87% | 6.88% | 12.56% | 4.34% | 4.32% | 0.30% |
| Operating Income | 249.89M | 186.81M | 92.82M | 64.36M | 145.14M | 358.70M | 281.21M | 280.10M | 335.40M | 234.09M | 165.30M | 174.27M | 220.50M | 221.44M | 155.02M | 133.75M | 230.37M | 62.81M | 53.28M | -21.23M |
| Operating Income Ratio | 3.32% | 2.58% | 1.56% | 1.02% | 2.25% | 5.73% | 4.88% | 5.28% | 6.52% | 4.85% | 3.98% | 4.56% | 6.23% | 7.14% | 6.15% | 6.09% | 11.57% | 2.97% | 2.86% | -1.39% |
| Total Other Income/Expenses | 591.31M | 429.55M | 155.55M | 161.86M | 43.97M | 31.21M | 20.26M | 23.47M | 19.38M | 21.25M | 20.51M | 37.69M | 18.94M | 0.00 | 0.00 | 0.00 | -10.46M | -4.37M | -3.45M | -2.53M |
| Income Before Tax | 841.20M | 616.36M | 248.37M | 370.52M | 194.25M | 392.60M | 301.47M | 300.59M | 355.27M | 263.35M | 196.66M | 216.22M | 235.48M | 221.44M | 155.02M | 133.75M | 219.91M | 58.44M | 49.83M | -23.76M |
| Income Before Tax Ratio | 11.17% | 8.50% | 4.17% | 5.85% | 3.01% | 6.27% | 5.23% | 5.67% | 6.90% | 5.46% | 4.73% | 5.66% | 6.66% | 7.14% | 6.15% | 6.09% | 11.05% | 2.77% | 2.67% | -1.55% |
| Income Tax Expense | 212.78M | 169.68M | 63.27M | -93.89M | 71.05M | 148.86M | 119.82M | 107.25M | 128.62M | 101.79M | 72.77M | 74.18M | 79.19M | 74.23M | 63.75M | 55.00M | 98.03M | 28.43M | 29.80M | -3.06M |
| Net Income | 628.42M | 6.40B | 415.88M | 464.41M | 123.19M | 243.74M | 181.65M | 193.34M | 226.65M | 161.55M | 123.89M | 142.03M | 156.29M | 147.22M | 91.27M | 78.75M | 121.88M | 30.01M | 20.03M | -20.70M |
| Net Income Ratio | 8.35% | 88.22% | 6.98% | 7.33% | 1.91% | 3.89% | 3.15% | 3.65% | 4.40% | 3.35% | 2.98% | 3.72% | 4.42% | 4.74% | 3.62% | 3.59% | 6.12% | 1.42% | 1.07% | -1.35% |
| EPS | 44.47 | 452.73 | 29.43 | 32.87 | 8.72 | 17.25 | 12.86 | 24.13 | 29.19 | 20.80 | 15.95 | 18.29 | 20.13 | 18.96 | 11.68 | 9.71 | 15.03 | 4.00 | 3.03 | -1.47 |
| EPS Diluted | 44.47 | 452.73 | 29.43 | 32.87 | 8.72 | 17.25 | 12.86 | 24.13 | 29.19 | 20.80 | 15.95 | 18.29 | 20.13 | 18.96 | 11.68 | 9.71 | 15.03 | 4.00 | 3.03 | -1.47 |
| Weighted Avg Shares Out | 14.13M | 14.13M | 14.13M | 14.13M | 14.13M | 14.13M | 14.13M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M |
| Weighted Avg Shares Out (Dil) | 14.13M | 14.13M | 14.13M | 14.13M | 14.13M | 14.13M | 14.13M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M |
Source: https://incomestatements.info
Category: Stock Reports